BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 8797023)

  • 1. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Jackson A; Uphouse L
    Horm Behav; 1996 Jun; 30(2):145-52. PubMed ID: 8797023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
    Trevino A; Wolf A; Jackson A; Price T; Uphouse L
    Horm Behav; 1999 Jun; 35(3):215-23. PubMed ID: 10373334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
    Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
    Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
    Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
    D'Souza DN; Zhang Y; Damjanoska KJ; Carrasco GA; Sullivan NR; Garcia F; Battaglia G; Doncarlos LL; Muma NA; Van de Kar LD
    Neuroendocrinology; 2004; 80(1):31-41. PubMed ID: 15385710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WAY100635 and female rat lordosis behavior.
    Uphouse L; Wolf A
    Brain Res; 2004 Jul; 1013(2):260-3. PubMed ID: 15193537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAA-5-HT1A receptor interaction in the mediobasal hypothalamus.
    Guptarak J; Selvamani A; Uphouse L
    Brain Res; 2004 Nov; 1027(1-2):144-50. PubMed ID: 15494165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action.
    Jackson A; Uphouse L
    Brain Res; 1998 Jun; 796(1-2):299-302. PubMed ID: 9689482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lordosis in female hamsters and rats by 8-OH-DPAT treatment.
    Hebert TJ; Menard CS; Dohanich GP
    Physiol Behav; 1995 Mar; 57(3):523-7. PubMed ID: 7753891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuating effects of prior oestradiol benzoate priming on 5-HT-mediated lordosis behavior in rats are dose-dependent.
    Siddiqui A; Shaharyar S
    Acta Physiol Hung; 2007 Sep; 94(3):209-21. PubMed ID: 17853773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen modulates 5-HT(1A) agonist inhibition of lordosis behavior but not binding of [(3)H]-8-OH-DPAT.
    Jackson A; Etgen AM
    Pharmacol Biochem Behav; 2001 Feb; 68(2):221-7. PubMed ID: 11267626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
    Ahlenius S; Fernandez-Guasti A; Hjorth S; Larsson K
    Eur J Pharmacol; 1986 May; 124(3):361-3. PubMed ID: 2942412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
    Uphouse L; Maswood S; Jackson A; Brown K; Prullage J; Myers T; Shaheen F
    Pharmacol Biochem Behav; 2002 Jun; 72(3):533-42. PubMed ID: 12175449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
    Le Saux M; Di Paolo T
    J Psychiatry Neurosci; 2005 Mar; 30(2):110-7. PubMed ID: 15798786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
    Uphouse L; Maswood S; Jackson A
    Pharmacol Biochem Behav; 2000 Jun; 66(2):383-8. PubMed ID: 10880694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1A receptor antagonists and lordosis behavior.
    Uphouse L; Andrade M; Caldarola-Pastuszka M; Jackson A
    Neuropharmacology; 1996 Apr; 35(4):489-95. PubMed ID: 8793912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
    Selvamani A; Lincoln C; Uphouse L
    Behav Brain Res; 2007 Apr; 179(1):99-106. PubMed ID: 17336403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of metergoline and 8-OH-DPAT injections into arcuate nucleus and lateral hypothalamic area on feeding in female rats during the estrous cycle.
    Steffens SM; da Cunha IC; Beckman D; Lopes AP; Faria MS; Marino-Neto J; Paschoalini MA
    Physiol Behav; 2008 Oct; 95(3):484-91. PubMed ID: 18694771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I; Johansson C; Ogren SO
    Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and behavioral effects of 5-HT1A receptor agonist 8-OH-DPAT in a rat model of levodopa-induced motor complications.
    Ba M; Kong M; Ma G; Yang H; Lu G; Chen S; Liu Z
    Brain Res; 2007 Jan; 1127(1):177-84. PubMed ID: 17113046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.